‘Mycidac-C’
-
Nov 21 2013
Cadila Pharmaceuticals launches ‘Mycidac-C’ First of its kind drug in the world for treatment of Lung Cancer
Privately-held Cadila Pharmaceuticals today said it had launched Mycidac-C for…
Read more
Breaking News
- ticket title
- Healthcare Innovation in India to Double, $60 Billion Opportunity by 2028 Pharma services and healthtech account for 80% of the market,Biotech and Medtech emerge as greenshoots
- 1 in 5 people diagnosed with diabetes in the last 5 years are in the age group 18-30 years
- Remedium Lifecare Limited bags “Best Returns to the Investors Award” at Brandscouncil Ratings & Medilinks India Awards 2023
- Largest kidney stone removed using a new-minimally invasive Holmium laser with Moses 2.0 technology
- A Comprehensive Analysis of Spirulina’s Nutritional Value, Industrial Applications, and Market Potential
- Dr. Reddy’s opts for AWS as preferred cloud provider to develop affordable pharma therapies for patients worldwide
- StanPlus rebrands to RED.Health Announces four new business verticals to create India’s largest integrated Emergency ecosystem
- Gurugram’s first Oncoplastic Breast Preservation Surgery performed on 50-yr-old cancer patient at Medharbour Hospital
- Healthcare AI Firm Qritive Raises $7.5M to Expand into New Markets
- Pharma Leaders crown Industry leaders, Healthcare Experts, Noted Doctors at the 15th Annual Pharma Leaders Power Brand Awards 2022
